Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

The Crucial Significance of Lifestyle Changes

Any change towards a healthier lifestyle, even if it seems small, can have a great impact, particularly in patients with diabetes. These changes are never too late. In consequence, as physicians, we should always be attentive and never stop encouraging patients to adopt them.

La trascendental importancia de los cambios en el estilo de vidaPatients with diabetes who make changes to their lifestyle, such as eating healthy or becoming physically active, are at a lower risk of developing cardiovascular disease or even dying from cardiovascular causes than diabetic patients who fail to incorporate these healthy habits. The other piece of good news in this article that was recently published in J Am Coll Cardiol is that it is never too late to change.

 

Lifestyle modification is one of the fundamental aspects of diabetes management and adopting healthy behaviors is associated with a reduction in the risk of cardiometabolic diseases and mortality in the general population.


Read also: Are Abdominal Aortic Aneurysm Screening Programs Overstated?


This analysis included 11,527 patients diagnosed with type 2 diabetes who were followed up for 13.3 years. During that period, there were 2311 cardiovascular events.

 

The modifiable lifestyle factors registered included a healthy eating index score, smoking status (never, past, current), physical activity (≥150 minutes/week of moderate activity), and low-risk alcohol consumption (5-15 g/day for women and 5-30 g/day for men).


Read also: Urgent/Emergent TAVR: A Valid Option.


For those who adopted at least one of these low-risk lifestyle behaviors, there was a 38% reduction in the risk of cardiovascular disease compared with individuals who made no lifestyle changes. Of course, there was a gradient; the greater the change, the lower the risk. For those who adopted 3 or more lifestyle behaviors, the reduction in risk was even greater (hazard ratio [HR]: 0.48; 95% confidence interval [CI]: 0.40 to 0.59). Among individuals who changed the most, the reduction in risk entailed a reduction in mortality (HR: 0.32; 95% CI: 0.22-0.47) compared to those who made no change at all.

 

Conclusion

In patients with type 2 diabetes, the greater the adherence to a healthy lifestyle, the lower the incidence of cardiovascular disease and cardiovascular death. These findings support the enormous benefits of making lifestyle changes and the importance of medical advice for all of our patients.

 

Original title: Influence of Lifestyle on Incident Cardiovascular Disease and Mortality in Patients with Diabetes Mellitus.

Reference: Liu G et al. J Am Coll Cardiol. 2018;71:2867-2876.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...